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Original Article

Genetic variants of the 11 beta-hydroxysteroid
dehydrogenase type 1 gene influence metabolic
syndrome
Nayana Devang, Kapaettu Satyamoorthy, Padmalatha S Rai, Nandini M, Prabha Adhikari*
Email: prabha.raghuveer@gmail.com

Abstract
Background: Metabolic syndrome (metS) is the prominent public issue around the globe which contributes
to several diseases, including type 2 diabetes, obesity, and insulin resistance (IR). At a recent time, IR due to
cortisol excess has been implicated as part of metS etiology. The 11 beta- hydroxysteroid dehydrogenase type
1 (HSD11B1) gene that encodes 11 beta- hydroxysteroid dehydrogenase (11β-HSD1) enzyme has a pivotal
role in maintaining serum cortisol level against IR. The aim of this study was to detect the frequency of
HSD11B1 gene polymorphisms and their association with metS among the South Indian cohort. Methods:
Our study included 613 South Indians enrolled from the Kasturba Medical College hospital, Mangalore. Their
biochemical and anthropometric data were recorded. The genotyping of NC_000001.10:g.209880259T>G and
NC_000001.10:g.209875254G>A polymorphisms were carried out using amplification refractory mutation
system- polymerase chain reaction (ARMS-PCR). Results: NC_000001.10:g.209880259T>G polymorphism
of the HSD11B1 gene was associated with metS. We observed significantly higher postprandial blood sugar
(p=0.029) and lower high density lipoprotein (HDL) cholesterol (p=0.009) levels in control subjects with TG
genotype compared to those with TT genotype of the NC_000001.10:g.209880259T>G. The control subjects
with AA genotype of the NC_000001.10:g.209875254G>A had significantly lower diastolic blood pressure
(DBP) compared to those with wild GG genotype (p=0.001). The control subjects with the combination of TG
genotype of the NC_000001.10:g.209880259T>G and GG genotype of the NC_000001.10:g.209875254G>A
had significantly higher blood pressure (p<0.001), blood sugar (p<0.05) and triglyceride levels (p=0.007),
whereas those with the combination of TG genotype of the NC_000001.10:g.209880259T>G and GA genotype
of the NC_000001.10:g.209875254G>A had significantly higher total cholesterol (p=0.008) and low density
lipoprotein (LDL) cholesterol levels (p=0.023). Conclusions: In conclusion, NC_000001.10:g.209880259T>G
polymorphism of the HSD11B1 gene is associated with metS risk, including high blood sugar, blood pressure,
and lipid levels. NC_000001.10:g.209875254G>A polymorphism is not associated with metS risk in South
Indian cohort. The A allele of NC_000001.10:g.209875254G>A polymorphism appears to be protective against
hypertension.
Key words: Metabolic syndrome; single nucleotide polymorphism; 11 beta- hydroxysteroid dehydrogenase type 1

Introduction
Metabolic syndrome (metS) is a prediabetic
syndrome, with the prevalence of 35% in the
world (www.idf.org). The International Diabetes
Federation (IDF) defines metS as a condition where,

abdominal obesity is represented by higher waist
circumferences (> 80 cm in women and > 90 cm in
men), in addition to any two of these abnormalities:
Triglycerides > 150 mg/dl, high density lipoprotein
(HDL) < 40 mg/dl in males and < 50 mg/dl in
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females, blood pressure > 130/85 mmHg and fasting
blood sugar (FBS) > 100mg/dl. 1

subjects signed the written informed consent before
the commencement of the study.

Overexpression of
11beta- hydroxysteroid
dehydrogenase type 1 (HSD11B1) and cortisol
excess in metabolically active tissues plays a major
role in metS pathophysiology.2 Patients with metS
exhibit insulin resistance (IR), higher levels of
blood sugar and higher lipids due to excess of
cortisol generation by 11β-HSD1.3 Overexpression
of HSD11B1 in mice exhibited many features of
metS4. Masuzaki, H et al., have provided evidence
that HSD11B1 overexpression led to obesity that
was further exaggerated by a high -fat diet. These
mice also exhibited pronounced insulin- resistant
diabetes and, hyperlipidemia selectively in adipose
tissue to an extent similar to adipose tissue in obese
humans.5 Moreover, pharmacological inhibition of
11β-HSD1 in diabetic mice reportedly lowered blood
glucose and improved insulin sensitivity.6,7

Subjects, anthropometric and biochemical analysis

The 11beta- hydroxysteroid dehydrogenase
type 1 (HSD11B1) gene plays a crucial role in
regulating the 11β-HSD1 activity against cortisol
excess and IR.3 Polymorphisms in this gene can
develop diabetes and prediabetic conditions.8-10
The two single nucleotide polymorphisms
(SNPs); NC_000001.10:g.209880259T>G and
NC_000001.10:g.209875254G>A of HSD11B1
gene were selected based on minor allele frequency
(MAF>0.01) and literature studies. While the
NC_000001.10:g.209875254G>A SNP in HSD11B1
modifies transcription factor binding site and, the
NC_000001.10:g.209880259T>G in the third intron
acts as intronic enhancers8. Genetic association
studies have reported that these polymorphisms are
involved in different IR-related conditions, such as
type 2 diabetes (T2D), metS, and polycystic ovary
syndrome.8-12 Despite the prominent role of cortisol
excess in metabolic abnormalities, the associations
of HSD11B1 gene polymorphisms with metS have
not yet been intensively studied.
The current study investigated the association
between HSD11B1 polymorphisms and metS in
South Indian cohort.
Materials and Methods
Ethics Statement
The study was approved by the Manipal University
Ethics Committee. All the patients and control

This hospital- based case -controlled genetic
association study included 613 (204 metS and
409 control) subjects. MetS subjects were defined
according to the IDF diagnostic criteria13 by the
general medicine physician in the inpatient treatment
unit at Kasturba Medical College (KMC) hospital,
Mangalore. The control subjects were recruited
from those who attended the KMC hospital for a
routine health check-up, without the family history
of diabetes, and who had a FBS ≤ 100 mg/dl. Any
patients with diabetes, malignancy, inflammation,
and endocrine disorders were excluded from this
study.
Anthropometric (weight, waist circumference (WC)
and blood pressure (BP)) data were collected. The
WC was measured at the midpoint between the
distal rib and the iliac crest.14 Body mass index
(BMI) was calculated from weight and height
values.15 Systolic and diastolic blood pressure (SBP/
DBP) were measured using sphygmomanometer.
All biochemical data (FBS, postprandial blood sugar
(PPBS), lipids such as total cholesterol (TC), HDL,
low- density lipoprotein (LDL), and triglycerides
(TGs) were measured following manufacturer’s
manual using 917 Hitachi auto-analyser.16,17
Genomic DNA extraction and SNP genotyping
Genomic DNA was extracted from the peripheral
venous blood of each participant using a
commercially available genomic DNA purification
kit
(Bioserve
Biotechnologies,
Hyderabad,
India) according to the instructions of the
manufacturer. We selected two SNPs in the
HSD11B1 gene (NC_000001.10:g.209880259T>G
and NC_000001.10:g.209875254G>A) based on
previous indications, that were studied with risk
factors for T2D with a minor allele frequency
> 0.5. Genotyping of SNPs was performed
with amplification refractory mutation systempolymerase chain reaction (ARMS-PCR) using two
pairs of primers.
The primers used for
NC_000001.10:g.209880259T>G were as follows:
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Outer forward primer:
5’-TTTCTGCTGTATCACTGCAGGTGGTATC-3’
Outer reverse primer:
5’-CAGCTACAGTCAGGACCACGTAACTGAG-3’
Inner forward primer:
5’-AGAATGGGAAAGGTATCAACCCCAAAT-3’
Inner reverse primer:
5’-CCTGCAAGAGATGGCTATATTAAGAAACCC-3’
The primers used for NC_000001.10:g.209875254G>A
were as follows:
Outer forward primer:
5’-CTCCTCACATTTTTGCCATCTCCTATCA-3’
Outer reverse primer:
5’-ACAGTGAACAGTTCACTCCACTCCTTGC-3’
Inner forward primer:
5’-GTGCTTGATTCCATTTATTCTGGGGG-3’
Inner reverse primer:
5’-CCAGGAATTCTCTCTGATTTGATCATGCT-3’

The ARMS-PCR was conducted in a final volume
of 25μl, containing 50 ng of template DNA, 4 mM
each dNTPs, 10 pm/µl of forward and reverse
outer primers, 10 pm/µl of forward and reverse
inner primers, and 1 U of Taq DNA polymerase
in the buffer supplied by the manufacturer (New
England Biolabs, USA). After initial denaturation
at 95°C for 5 min, 35 cycles were run at 95°C,
60°C (NC_000001.10:g.209880259T>G) or 58°C
(NC_000001.10:g.209875254G>A) and 72°C for 1
min each, followed by one cycle of final extension at
72°C for 10 min using PCR (Master cycler thermal
cycler). PCR products were then separated by agarose
gel electrophoresis at 100 V for 30 minutes and the
bands were visualized under UV gel documentation
system (Uvitec, UK). Positive and negative controls
were used with each PCR run in order to confirm
the precision of the genotyping outcome.
Statistical Analysis
Clinical parameters were presented as mean ±
standard deviation. All the statistical tests were
performed using SPSS v. 20 (IBM SPSS Inc., Chicago,
IL, USA).18 Statistical power was calculated using a
web browser program, Genetic Power Estimator
(http://osse.bii.a-star.edu.sg/).
The
HardyWeinberg equilibrium (HWE) was determined
using Pearson’s λ2 test for each SNPs. The odds
ratio (OR) and 95% CI were calculated to find the
10
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genetic association with metS. Two sample t-test
was used for the comparison of clinical parameters
between genotypes of two SNPs. One-way analysis
of variance (ANOVA) was used for the comparison
of clinical parameters between the diplotypes of
two SNPs. The p values < 0.05 were considered
statistically significant.
Results
In the South Indian cohort, 58.8% were women and
41.2% were men, and their average age was 55.92
± 12.03 years. The most common metS component
was higher blood sugar (52.59%), followed by lower
HDL levels (52.33%), and hypertension was the last
common metS component (17.37%) (Table 1). The
BMI, WC, BP, FBS, and TGs were significantly
higher in metS cases than controls (p<0.001).
HDL was significantly lower in cases than control
(p<0.001). There was no significant difference in TC
and LDL levels between cases and controls (Table
2).
Table 1: Characteristics of the South Indian cohort
Women

58.8%

Men

41.2%

Age

55.9212.03

Waist circumference

50.24%

BP (>130/85 mmHg)

17.37%

TGs (>150 mg/dl)

30.88%

Glucose (>100 mg/dl)

52.59%

HDL
52.33%
Age = mean ± standard deviation, Waist circumference (> 90
cm men or > 80 cm women), HDL (< 40 men or < 50 mg/dl
women).
Table 2: Clinical characteristics of the metS and control subjects.
Phenotype

metS

Control

P value

Age (Years)

55.9212.03

13.17

0.245

BMI (Kg/m2)

27.784.66

24.343.03

<0.001**

WC (cm)

95.5411.06

87.429.84

<0.001**

SBP (mmHg)

141.9914.72

124.9711.03

<0.001**

DBP (mmHg)

85.1610.59

78.625.98

<0.001**

FBS (mg/dl)

124.8145.10

97.619.65

<0.001**

PPBS (mg/dl)

175.4285.61

102.6525.11

<0.001**

TC (mg/dl)

200.3749.30

193.7139.73

0.184

HDL (mg/dl)

41.319.49

51.9214.04

<0.001**

LDL (mg/dl)

130.2740.67

126.7636.18

0.2

TGs (mg/dl)

167.9972.34

109.4748.54

<0.001**

Data are shown as mean standard deviation. **Significant P
value <0.001. BMI, body mass index; WC, waist circumference;
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SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS,
fasting blood sugar; PPBS, Postprandial blood sugar; TC, total
cholesterol; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; TGs,triglycerides; metS, metabolic syndrome.

Genotyping of DNA samples in duplicate by
ARMS-PCR showed 100% concordance. For TT
genotype of NC_000001.10:g.209880259T>G,
two bands of 383 bp (amplicon size for two outer
primers) and 185 bp (amplicon size for T allelespecific inner forward primer) were generated. For
TG genotype of NC_000001.10:g.209880259T>G,
three bands of 383 bp, 185 bp, and 255 bp (amplicon
size for G allele-specific inner reverse primer)
were generated. Similarly, for GG genotype of
NC_000001.10:g.209875254G>A, the two bands
of 300 bp (amplicon size for two outer primers)
and 199 bp (amplicon size for G allele-specific inner
forward primer) were generated. For GA genotype
of NC_000001.10:g.209875254G>A three bands of
300 bp, 199 bp, and 160 bp (amplicon size for A allele
specific inner reverse primer) were generated.
The

genotype

distributions

of
NC_000001.10:g.209880259T>G
and
NC_000001.10:g.209875254G>A polymorphisms of the
HSD11B1 gene were in HWE among the cases and
the controls (p>0.05). The South Indian cohort
included 613 subjects with 204 metS (33%) and 409
controls (67%). The frequency of G allele and TG
genotype of NC_000001.10:g.209880259T>G SNP
were significantly higher in cases than in controls.
However, the A allele frequency and GA genotype
frequency of NC_000001.10:g.209875254G>A
polymorphism did not show significant differences
between cases and controls (Tables 3). We
observed positive association between metS and
NC_000001.10:g.209880259T>G
polymorphism

(Allelic OR=2.13, CI=1.56-2.91), p<0.0001).
However, no association was observed between
NC_000001.10:g.209875254G>A
polymorphism
and metS (Allelic OR=1.26, CI=0.85-1.85, p=0.23)
in South Indian cohort (Table 3).
We observed significantly higher PPBS and
lower HDL levels in controls with TG genotype
of NC_000001.10:g.209880259T>G compared
to those with wild TT genotype (Table 4).
NC_000001.10:g.209875254G>A
polymorphism
was not associated with metS. However, this SNP
appears to have the negative association with BP.
The controls with polymorphic GA genotype of
NC_000001.10:g.209875254G>A had significantly
lower DBP compared to those with wild GG
genotype (p=0.001) (Table 4). Since cases were
on medications, assessment of the association of
HSD11B1 SNPs with clinical parameters was not
performed.
Diplotype analyses show that, the control
subjects with the combination of TG genotype
of NC_000001.10:g.209880259T>G and GG
genotype of
NC_000001.10:g.209875254G>A
has significantly higher BP, blood sugar, and TGs.
The control subjects with the combination of TG
genotype of NC_000001.10:g.209880259T>G and
GA genotype of NC_000001.10:g.209875254G>A
had significantly higher TC and LDL levels (Table
5).
Discussion
The HSD11B1 gene encodes the cortisone reductase
11β-HSD1 enzyme, which has a pivotal role in
glucocorticoid metabolism.2, 18 Variations in the
transcription enhancer site of the third intron

Table 3: Genotype and allele frequencies of NC_000001.10:g.209880259T>G and NC_000001.10:g.209875254G>A polymorphisms
in the South Indians
Allele frequency

Genotype frequency

(HSD11B1)
NC_000001.10:g.209880259T>G

(HSD11B1)
NC_000001.10:g.209875254G>A

(HSD11B1)
(HSD11B1)
NC_000001.10:g.209880259T>G NC_000001.10:g.209875254G>A

T

G

G

A

TT

TG

GG

GA

metS (n=204)

0.77

0.23

0.89

0.11

0.54

0.46

0.77

0.23

Control(n=409)

0.88

0.12

0.91

0.09

0.75

0.25

0.81

0.19

OR (CI)

2.13 (1.56-2.91)

1.26 (0.85-1.85)

2.62 (1.84-3.74)

1.29 (0.86-1.95)

P value

<0.0001

0.23

<0.0001

0.21

OR, odds ratio; CI, confidence interval; metS, metabolic syndrome.
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Table 4: Association of HSD11B1 polymorphisms with clinical components in control cohort
Phenotype

(HSD11B1) NC_000001.10:g.209880259T>G

(HSD11B1) NC_000001.10:g.209875254G>A

TT (n=307)

TG (n=101)

p

GG (n=332)

AG (n=76)

p

BMI (kg/m2)

24.21 ± 3.28

24.73 ± 3.35

0.427

24.40 ± 3.43

24.07 ± 2.67

0.07

WC (cm)

86.87 ± 9.69

89.11 ± 10.16

0.224

87.71 ± 9.86

86.17 ± 9.73

0.287

SBP (mmHg)

123.95 ± 10.36

128.15 ± 12.42

0.148

126.20 ± 11.26

119.34 ± 7.76

0.417

DBP (mmHg)

78.43 ± 6.5

79.21 ± 3.89

0.147

79.44 ± 5.81

74.89 ± 5.34

0.001*

FBS (mg/dl)

97.25 ± 10.33

98.67 ± 7.26

0.195

97.99 ± 9.77

96.19 ± 9.14

0.345

PPBS (mg/dl)

99.34 ± 22.01

111.53 ± 30.58

0.029*

105.64 ± 25.51

91.21 ± 20.06

0.287

TC (mg/dl)

189.37 ± 36.58

206.75 ± 45.94

0.827

195.77 ± 41.79

186.42 ± 30.71

0.113

HDL (mg/dl)

53.02 ± 15.38

48.56 ± 7.96

0.009*

52.64 ± 14.93

49.38 ± 10.06

0.092

LDL (mg/dl)

122.75 ± 34.38

138.37 ± 39.01

0.357

127.93 ± 37.8

122.36 ± 29.3

0.384

TGs (mg/dl)
103.47 ± 45.43
127.22 ± 53.38
0.773
110.18 ± 54.00
106.98 ± 20.44
0.545
Data expressed as mean ± standard deviation. *Significant p value <0.05. BMI, body mass index; WC, waist circumference; SBP,
systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; PPBS, Postprandial blood sugar; TC, total cholesterol;
HDL, high density lipoprotein; LDL, low density lipoprotein; TGs, triglycerides.
Table 5: Association of the combination of NC_000001.10:g.209880259T>G and NC_000001.10:g.209875254G>A polymorphisms
with clinical components in control cohort
Phenotype

(HSD11B1) NC_000001.10:g.209880259T>G,
(HSD11B1) NC_000001.10:g.209875254G>A

p

TG, GA (n=15)

TG, GG (n=86)

TT, GA (n=61)

TT, GG (n=246)

BMI (kg/m2)

23.87 ± 2.82

24.88 ± 3.41

24.13 ± 2.66

24.23 ± 3.41

0.369

WC (cm)

86.13 ± 9.78

89.64 ± 10.19

86.2 ± 9.81

87.04 ± 9.68

0.115

SBP (mmHg)

124.75 ± 6.01

128.63 ± 13.02

118.28 ± 7.66

125.36 ± 10.47

<0.001**

DBP (mmHg)

78.58 ± 2.77

79.5 ± 4.03

74.16 ± 5.44

79.48 ± 6.32

<0.001**

FBS (mg/dl)

92.07 ± 8.15

100.18 ± 6.17

97.4 ± 9.13

97.21 ± 10.67

0.025*

PPBS (mg/dl)

90.14 ± 24.76

116.35 ± 30.00

91.55 ± 19.00

101.49 ± 22.41

0.001*

TC (mg/dl)

207.4 ± 21.41

206.47 ± 53.21

175.93 ± 29.47

192.64 ± 37.49

0.008*

HDL (mg/dl)

48.47 ± 5.18

48.63 ± 8.96

49.83 ± 11.79

53.79 ± 16.08

0.128

LDL (mg/dl)

139 ± 22.72

138.11 ± 44.36

113.15 ± 28.75

124.92 ± 35.25

0.023*

TGs (mg/dl)
109.6 ± 21.86
134.56 ± 60.76
105.67 ± 19.94
102.93 ± 49.82
0.007*
Data expressed as mean ± standard deviation. **Significant p value <0.001, *Significant p value <0.05. BMI, body mass index; WC,
waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; PPBS, Postprandial blood
sugar; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; TGs, triglycerides.

(NC_000001.10:g.209880259T>G) and promoter
region
(NC_000001.10:g.209875254G>A)
of
HSD11B1 may modulate the HSD11B1 transcription
and expression levels9.
Though previous studies assessed the association
of HSD11B1 polymorphisms with several insulin
resistance related conditions, including abdominal
obesity, dyslipidaemia, hypertension, polycystic
ovary syndrome, and T2D2,11,12, none of the
studies gave sufficient evidence. All previous
studies gave conflicting association of HSD11B1
gene polymorphisms with metS. MetS is a major
public health problem. Recently, the role of
12

Published by Impressions@MAHE, 2021

glucocorticoid excess in the pathophysiology
of this entity has been widely reported. Our
present investigation of the involvement of
HSD11B1 (NC_000001.10:g.209880259T>G and
NC_000001.10:g.209875254G>A) polymorphisms
in the metS susceptibility within a South Indian
cohort attending tertiary care hospital revealed that,
the NC_000001.10:g.209880259T>G polymorphism
was associated with metS. In accordance with
our finding, a previous study reported that, the
combination of NC_000001.10:g.209880259T>G
and
NC_000001.10:g.209875254G>A
polymorphisms showed positive association with
metS in South European women.9 The frequency
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of HSD11B1 NC_000001.10:g.209880259T>G
genotype observed in our study is similar to the
findings of Asian study which reported a 33.7%
prevalence of NC_000001.10:g.209880259T>G
genotype in Koreans with metS10. However, there
was no significant difference in the frequency of
TG genotype between cases and controls (p=0.197)
in Koreans. As a result, there was no association of
NC_000001.10:g.209880259T>G
polymorphism
with metS in their study. Moreover, their cases
and controls were not age-matched. Unlike our
study, the number of controls used by them was
significantly lower than cases. Similarly, there was
no association of NC_000001.10:g.209880259T>G
and
NC_000001.10:g.209875254G>A
gene
polymorphisms with metS in Bosnians, Euro
Brazilians, and American Indians19-21. Reason for
this discrepancy may be the use of different ethnic
groups, inadequate sample size and lack of matching
control samples.

not seem to be protective against high cholesterol
values.

The
G
allele
carriers
of
NC_000001.10:g.209880259T>G had significantly
higher PPBS and lower HDL levels. Similarly, previous
study on South European women reported that the G
allele carriers of NC_000001.10:g.209880259T>G
had significantly higher blood sugar (p=0.006) and
lower HDL (p=0.011) than T allele carriers9. The
effect of HSD11B1 on blood sugar and lipid seems
to be mediated by excess cortisol production due
to HSD11B1 overexpression. In concordance with
our study, an Asian study showed significantly
higher values DBP (p=0.014) in A allele carriers of
NC_000001.10:g.209875254G>A than those with
wild G allele among Koreans10. Similarly, A allele
carriers of NC_000001.10:g.209875254G>A had
significantly higher values of DBP in American
Indians21 and South European women9 compared
to those with wild G allele. Since hypertension is a
multifactorial condition, the influence of HSD11B1
polymorphism on BP may not be straightforward
and may be modified by environmental as well as
other genetic factors.

Conclusions
The present study provides evidence that,
NC_000001.10:g.209880259T>G
polymorphism
of the HSD11B1 gene is associated with high risk
of metS, hyperglycaemia, blood pressure and low
levels of HDL. NC_000001.10:g.209875254G>A
polymorphism of HSD11B1 seems to pose a lower
risk of hyperglycaemia and hypertension. Further
studies with larger sample size are necessary to
confirm these data.

Our
study
reveals
that,
the
NC_000001.10:g.209875254G>A
polymorphism
may be protective against hypertension due to the
significantly lower BP in the carriers of this SNP
compared to wild genotype. However, this SNP does

The sample size used in our study to assess the
association of HSD11B1 polymorphism with
metS is larger than all the previous studies. The
study used two SNPs after assessing rare allele
frequencies (>5%) and was based on the studies of
literature. However, other SNPs may also influence
metS in the study cohort. So further studies must
assess the association of other SNPs with metS
and associated components. Clinical analysis of the
cases was not possible due to the use of medications
by the majority of cases. Future studies must use
medication naive subjects.
Supporting the study results, selective drug designing
to inhibit the HSD11B1 over expression may help to
reverse the abnormal clinical profile of metS subjects
with HSD11B1 NC_000001.10:g.209880259T>G
gene polymorphism.
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